Lachey Jennifer
Insider CIK 1808322 · KROS Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2022-07-15 | 2022-07-19 | 46,034 | — | $0 | 8,755 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-07-15 | 2022-07-19 | 46,034 | $30.00 | $1.38M | 95,100 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2022-07-15 | 2022-07-19 | 46,034 | $0.30 | $13.8K | 141,134 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2022-07-13 | 2022-07-15 | 1,916 | — | $0 | 54,789 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-07-13 | 2022-07-15 | 1,916 | $30.00 | $57.5K | 95,100 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2022-07-13 | 2022-07-15 | 1,916 | $0.30 | $575 | 93,184 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2022-06-14 | 2022-06-14 | 9,400 | — | $0 | 56,705 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2022-06-14 | 2022-06-14 | 9,400 | $0.30 | $2.8K | 95,100 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2022-05-11 | 2022-05-13 | 5,300 | — | $0 | 66,105 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-13 | 16 | $45.45 | $727 | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-13 | 223 | $44.23 | $9.9K | 85,716 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-13 | 719 | $43.32 | $31.1K | 85,939 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-13 | 944 | $42.49 | $40.1K | 86,658 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-13 | 3,398 | $41.26 | $140.2K | 87,602 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2022-05-11 | 2022-05-13 | 5,300 | $0.30 | $1.6K | 91,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2022-04-11 | 2022-04-13 | 5,300 | — | $0 | 71,405 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2022-04-11 | 2022-04-13 | 5,300 | $0.30 | $1.6K | 91,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-04-11 | 2022-04-13 | 2,315 | $63.50 | $147.0K | 86,259 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-04-11 | 2022-04-13 | 559 | $64.15 | $35.9K | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-04-11 | 2022-04-13 | 1,009 | $62.32 | $62.9K | 88,574 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-04-11 | 2022-04-13 | 1,417 | $61.37 | $87.0K | 89,583 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2022-04-04 | 2022-04-06 | 7,950 | — | $0 | 76,705 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-04-04 | 2022-04-06 | 7,950 | $60.00 | $477.0K | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2022-04-04 | 2022-04-06 | 7,950 | $0.30 | $2.4K | 93,650 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2022-03-11 | 2022-03-15 | 2,650 | — | $0 | 84,655 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-03-11 | 2022-03-15 | 875 | $54.54 | $47.7K | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2022-03-11 | 2022-03-15 | 2,650 | $0.30 | $795 | 88,350 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-03-11 | 2022-03-15 | 1,062 | $52.43 | $55.7K | 87,288 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-03-11 | 2022-03-15 | 713 | $53.36 | $38.0K | 86,575 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2022-02-11 | 2022-02-15 | 2,650 | — | $0 | 87,305 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-02-11 | 2022-02-15 | 1,378 | $52.35 | $72.1K | 85,899 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2022-02-11 | 2022-02-15 | 2,650 | $0.30 | $795 | 88,350 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-02-11 | 2022-02-15 | 1,073 | $51.50 | $55.3K | 87,277 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-02-11 | 2022-02-15 | 199 | $53.10 | $10.6K | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2022-01-21 | 2022-01-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2022-01-11 | 2022-01-13 | 2,650 | — | $0 | 89,955 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-01-11 | 2022-01-13 | 320 | $52.01 | $16.6K | 88,030 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-01-11 | 2022-01-13 | 1,196 | $53.56 | $64.1K | 86,834 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-01-11 | 2022-01-13 | 1,134 | $54.45 | $61.7K | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2022-01-11 | 2022-01-13 | 2,650 | $0.30 | $795 | 88,350 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2022-01-05 | 2022-01-07 | 2,650 | — | $0 | 92,605 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2022-01-05 | 2022-01-07 | 2,650 | $60.00 | $159.0K | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2022-01-05 | 2022-01-07 | 2,650 | $0.30 | $795 | 88,350 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-12-15 | 2021-12-15 | 735 | — | $0 | 95,255 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-12-15 | 2021-12-15 | 735 | $50.00 | $36.8K | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-12-15 | 2021-12-15 | 735 | $0.30 | $221 | 86,435 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-12-13 | 2021-12-15 | 1,915 | — | $0 | 95,990 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-12-13 | 2021-12-15 | 1,915 | $0.30 | $575 | 87,615 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-12-13 | 2021-12-15 | 7 | $53.64 | $375 | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-12-13 | 2021-12-15 | 1,518 | $50.11 | $76.1K | 86,097 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-12-13 | 2021-12-15 | 390 | $52.22 | $20.4K | 85,707 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-11-11 | 2021-11-12 | 5,300 | — | $0 | 97,905 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-11-11 | 2021-11-12 | 739 | $58.73 | $43.4K | 90,261 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-11-11 | 2021-11-12 | 4,561 | $59.78 | $272.7K | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-11-11 | 2021-11-12 | 5,300 | $0.30 | $1.6K | 91,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-11-10 | 2021-11-12 | 15,900 | — | $0 | 103,205 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-11-10 | 2021-11-12 | 15,900 | $0.30 | $4.8K | 101,600 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-11-10 | 2021-11-12 | 15,900 | $60.00 | $954.0K | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-11-04 | 2021-11-05 | 10,600 | — | $0 | 119,105 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-11-04 | 2021-11-05 | 10,600 | $50.00 | $530.0K | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-11-04 | 2021-11-05 | 10,600 | $0.30 | $3.2K | 96,300 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-08-17 | 2021-08-18 | 1,293 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-08-17 | 2021-08-18 | 1,293 | $0.30 | $388 | 85,700 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-06-24 | 2021-06-25 | 6,500 | — | $0 | 1,293 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-06-24 | 2021-06-25 | 6,500 | $0.30 | $1.9K | 84,407 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-06-11 | 2021-06-15 | 2,650 | — | $0 | 129,705 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-06-11 | 2021-06-15 | 2,650 | $0.30 | $795 | 80,557 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-06-11 | 2021-06-15 | 1,533 | $50.37 | $77.2K | 79,024 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-06-11 | 2021-06-15 | 219 | $52.13 | $11.4K | 77,907 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-06-11 | 2021-06-15 | 898 | $51.73 | $46.5K | 78,126 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-05-13 | 2021-05-13 | 500 | — | $0 | 7,793 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-05-13 | 2021-05-13 | 6,220 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-05-13 | 2021-05-13 | 500 | $0.30 | $150 | 77,907 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-05-13 | 2021-05-13 | 6,220 | $0.11 | $684 | 77,407 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-05-11 | 2021-05-13 | 2,650 | — | $0 | 132,355 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-05-11 | 2021-05-13 | 2,650 | $50.00 | $132.5K | 71,187 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-05-11 | 2021-05-13 | 2,650 | $0.30 | $795 | 73,837 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-04-12 | 2021-04-14 | 5,300 | — | $0 | 135,005 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-14 | 3,473 | $59.99 | $208.3K | 72,016 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-14 | 729 | $61.08 | $44.5K | 71,287 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-14 | 100 | $61.72 | $6.2K | 71,187 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-14 | 998 | $59.10 | $59.0K | 75,489 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-04-12 | 2021-04-14 | 5,300 | $0.30 | $1.6K | 76,487 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-04-01 | 2021-04-02 | 9,996 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-04-01 | 2021-04-02 | 9,996 | $0.11 | $1.1K | 71,187 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-03-11 | 2021-03-15 | 5,300 | — | $0 | 140,305 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-03-11 | 2021-03-15 | 4 | $65.47 | $262 | 61,191 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-03-11 | 2021-03-15 | 3,557 | $64.72 | $230.2K | 61,195 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-03-11 | 2021-03-15 | 1,739 | $63.99 | $111.3K | 64,752 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-03-11 | 2021-03-15 | 5,300 | $0.30 | $1.6K | 66,491 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-02-26 | 2021-03-01 | 33,200 | — | $0 | 9,996 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-02-26 | 2021-03-01 | 33,200 | $0.11 | $3.7K | 61,191 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise deriv | 2021-02-11 | 2021-02-16 | 5,300 | — | $0 | 145,605 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 14 | $68.05 | $953 | 27,991 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 262 | $67.05 | $17.6K | 28,005 | SEC↗ |
| KROS Keros Therapeutics, Inc. | M Exercise | 2021-02-11 | 2021-02-16 | 5,300 | $0.30 | $1.6K | 33,291 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 447 | $62.85 | $28.1K | 32,844 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 1,460 | $63.74 | $93.1K | 31,384 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 1,272 | $64.93 | $82.6K | 30,112 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2021-02-11 | 2021-02-16 | 1,845 | $65.99 | $121.8K | 28,267 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2021-01-10 | 2021-01-12 | 42,250 | — | $0 | 42,250 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award deriv | 2020-04-07 | 2020-04-08 | 241,222 | — | $0 | 241,222 | SEC↗ |